Ann: Lumos Receives US FDA Clearance for FebriDx, page-263

Market size roughly $2.5bUS P.A. addressable straight up.
I’d say conservatively 5% uptake, $125mUS.

Now the part I am unsure about is the deal between Atomo(ASX; AT1) and us, in regards to what percentages.
From AT1 prospectus;
“For the term of each OEM Distribution Agreement, the Company agrees to supply the relevant product to the OEM Distributor at an agreed price and in the quantities requested by the OEM Distributor. Each year of each of the OEM Distribution Agreements has minimum purchase amounts that must be made by the OEM Distributor.” Found here; Page114 https://www.asx.com.au/asxpdf/20200414/pdf/44gxxmxt2bfgc0.pdf

So I’d expect a commercialisation agreement being discussed and announced over the next few weeks between the two companies on figures etc.

A good spot to be in for both companies.